We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M Turnover 17.24%
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
+5.53%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$559M
AUM Growth
-$6.54M
Cap. Flow
-$4.83M
Cap. Flow %
-0.87%
Top 10 Hldgs %
65.7%
Holding
77
New
3
Increased
6
Reduced
4
Closed
2
Avg Time Held
0.5 years
Top 10 Avg Time Held
0.6 years
Top 20 Avg Time Held
0.6 years

Top Buys

Rank Stock Value
1
FGNA.U
FG New America Acquisition Corp. Units, each consisting of one share of Class A common stock and one
FGNA.U
+$5M
2
ADVM icon
Adverum Biotechnologies
ADVM
+$2.25M
3
TGTX icon
TG Therapeutics
TGTX
+$1.61M
4
MRNS icon
Marinus Pharmaceuticals, Inc
MRNS
+$1.02M
5
FATE icon
Fate Therapeutics
FATE
+$697K

Top Sells

Rank Stock Value
1
ARKO icon
ARKO Corp
ARKO
+$10.3M
2
BLFS icon
BioLife Solutions
BLFS
+$3.46M
3
FLNA icon
Filana Therapeutics
FLNA
+$1.65M
4
DRRX icon
DURECT Corp
DRRX
+$501K
5
CUE icon
Cue Biopharma
CUE
+$288K

Sector Composition

Rank Sector Weight
1 Healthcare 26.25%
2 Industrials 17.34%
3 Miscellaneous 16.1%
4 Energy 10.35%
5 Materials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
GLD icon
1
SPDR Gold Trust
GLD
$141B
$84.1M 15.05%
475,000
– –
2019 Q4
3 quarters
RPRX icon
2
Royalty Pharma
RPRX
$26.5B
$46.9M 8.4%
1,115,980
– –
2020 Q2
1 quarter
LIN icon
3
Linde
LIN
$228B
$45.9M 8.21%
192,627
– –
2019 Q4
3 quarters
DRRX icon
4
DELISTED
DURECT Corp
DRRX
$45.2M 8.08%
2,641,466
-25,000
-0.9% -$501K
2019 Q4
3 quarters
DCP
5
DELISTED
DCP Midstream, LP
DCP
$31.8M 5.69%
2,848,805
– –
2019 Q4
3 quarters
XRX icon
6
Xerox
XRX
$348M
$31.5M 5.63%
1,676,225
– –
2019 Q4
3 quarters
IVAC icon
7
DELISTED
Intevac Inc
IVAC
$27.3M 4.88%
4,949,355
– –
2019 Q4
3 quarters
IDN icon
8
Intellicheck
IDN
$45.2M
$18.3M 3.27%
2,738,314
– –
2019 Q4
3 quarters
LIQT icon
9
LiqTech
LIQT
$12.5M
$18.2M 3.26%
269,806
+937
+0.3% +$51.7K
2020 Q1
2 quarters
BC icon
10
Brunswick
BC
$4.22B
$18M 3.23%
306,099
– –
2020 Q1
2 quarters
OPTU icon
11
Optimum Communications Inc
OPTU
$365M
$15.7M 2.81%
603,600
– –
2020 Q1
2 quarters
SPGI icon
12
S&P Global
SPGI
$125B
$14.4M 2.58%
40,000
– –
2019 Q4
3 quarters
INVE icon
13
INVE Technologies, Inc. Common Stock
INVE
$55.5M
$13.7M 2.46%
2,196,389
– –
2019 Q4
3 quarters
AMAG
14
DELISTED
AMAG Pharmaceuticals
AMAG
$12.2M 2.19%
1,299,994
– –
2019 Q4
3 quarters
NGL icon
15
NGL Energy Partners
NGL
$1.85B
$10.8M 1.92%
2,714,937
– –
2019 Q4
3 quarters
THO icon
16
Thor Industries
THO
$3.6B
$10.5M 1.87%
109,753
– –
2020 Q1
2 quarters
SHLX
17
DELISTED
Shell Midstream Partners, L.P.
SHLX
$8.64M 1.55%
913,347
– –
2019 Q4
3 quarters
GRA
18
DELISTED
W.R. Grace & Co.
GRA
$8.1M 1.45%
200,934
– –
2020 Q1
2 quarters
FLNA icon
19
Filana Therapeutics
FLNA
$36.6M
$7.88M 1.41%
684,503
-366,000
-35% -$1.65M
2019 Q4
3 quarters
LSXMK icon
20
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$7.82M 1.4%
305,187
– –
2019 Q4
3 quarters
MRNS icon
21
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$7.46M 1.33%
580,462
+117,962
+26% +$1.02M
2020 Q1
2 quarters
CDXS icon
22
Codexis
CDXS
$147M
$6.8M 1.22%
579,116
+9,280
+2% +$116K
2019 Q4
3 quarters
EOSE icon
23
Eos Energy Enterprises
EOSE
$736M
$5M 0.9%
500,000
– –
2020 Q2
1 quarter
FGNA.U
24
DELISTED
FG New America Acquisition Corp. Units, each consisting of one share of Class A common stock and one
FGNA.U
$5M 0.9%
+500,000
New +$5M
2020 Q3
0 quarters
CDNA icon
25
CareDx
CDNA
$3.47B
$4.74M 0.85%
125,000
– –
2019 Q4
3 quarters
1
2 3 4

Similar funds

NFW
Noble Family Wealth Clearwater, Florida $559M AUM 24.35% 1-Year Est. Return
SCM
Soros Capital Management New York $559M AUM 171.77% 1-Year Est. Return
PHC
Palidye Holdings (Caymans) Grand Cayman, Cayman Islands $559M AUM 1.08% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
BCM
Brasada Capital Management Houston, Texas $558M AUM 21.68% 1-Year Est. Return
FAM
Frontier Asset Management Sheridan, Wyoming $558M AUM 22.41% 1-Year Est. Return
WDG
Wealth Dimensions Group Cincinnati, Ohio $558M AUM 20.63% 1-Year Est. Return
OC
Opal Capital Boca Raton, Florida $560M AUM

Bleichroeder LP's Q3 2020 Portfolio in Review

As of Q3 2020, Bleichroeder LP held 77 positions worth $559M, down 1.2% from $565M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Bleichroeder LP's Q3 2020 filing shows 3 new, 6 increased, 4 reduced and 2 closed positions. Its largest new stake was FG New America Acquisition Corp. Units, each consisting of one share of Class A common stock and one: 500,000 shares worth $5M. The largest sale was ARKO Corp, an estimated $10.3M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 29% a quarter earlier, followed by Industrials and Miscellaneous.

  • Bleichroeder LP's largest Q3 2020 buy was FG New America Acquisition Corp. Units, each consisting of one share of Class A common stock and one: 500,000 shares worth $5M.
  • Bleichroeder LP added most to Marinus Pharmaceuticals, Inc in Q3 2020, an estimated $1.02M increase.
  • Bleichroeder LP's biggest Q3 2020 reduction was Filana Therapeutics, cutting an estimated $1.65M.
  • Bleichroeder LP fully exited ARKO Corp in Q3 2020, selling an estimated $10.3M.
  • Bleichroeder LP's ten largest holdings make up 66% of its $559M portfolio in Q3 2020.
  • Bleichroeder LP opened 3 new positions and closed 2 in Q3 2020.
  • Bleichroeder LP's portfolio value fell 1.2% quarter-over-quarter to $559M.

Based on Bleichroeder LP's 13F filing for Q3 2020, filed 12 Nov 2020.